Cybin to Host CYB003 Topline Depression Study Review and R&D Briefing on November 30, 2023, in New York City

- Company speakers include Doug Drysdale, Chief Executive Officer; and Amir Inamdar, MBBS, DNB , MFPM, Chief Medical Officer -


- Featured key opinion leaders include Dr. Maurizio Fava, M.D.,...

Related Keywords

Netherlands ,United Kingdom ,Massachusetts ,United States ,Copenhagen ,Køavn ,Denmark ,Canada ,New York ,Austria ,Ireland ,Vienna ,Wien ,Danish ,American ,Gittem Knudsen , ,Linkedin ,Health Canada ,Department Of Psychiatry The Massachusetts ,Carlsberg Foundation Researcher Award For Sciences ,Program Schedule ,Psychiatry Clinical Trials Network ,Cybin Inc ,Exchange Commission ,National Academy Of Medicine ,University Of Vienna ,Clinical Trials Network ,Royal Danish Academy Of Sciences ,Panel Discussion ,Instagram ,University Of Padova School Medicine ,European College Of Neuropsychopharmacology ,Drug Administration ,Research Program ,Neurobiology Research Unit ,University Of Copenhagen ,Mental Health On ,Youtube ,American Society Of Clinical Psychopharmacology ,Current Treatment Landscape ,Therapeutic Potential ,New York City ,Maurizio Fava ,Massachusetts General Hospital ,Associate Dean ,Slater Family Professor ,Harvard Medical ,Padova School ,Depression Clinical ,American Society ,Clinical Psychopharmacology ,National Academy ,European College ,Human Brain ,Monrad Krohn Prize ,Niels Lassen Prize ,Carlsberg Foundation Researcher Award ,Royal Danish Academy ,Adjunct Professor ,Markets ,